308 related articles for article (PubMed ID: 22909549)
1. Porous PLGA scaffolds for controlled release of naked and polyethyleneimine-complexed DNA.
Ravi N; Gupta G; Milbrandt TA; Puleo DA
Biomed Mater; 2012 Oct; 7(5):055007. PubMed ID: 22909549
[TBL] [Abstract][Full Text] [Related]
2. Controlled and sustained gene delivery from injectable, porous PLGA scaffolds.
Jeon O; Krebs M; Alsberg E
J Biomed Mater Res A; 2011 Jul; 98(1):72-9. PubMed ID: 21538827
[TBL] [Abstract][Full Text] [Related]
3. Hydrophilized 3D porous scaffold for effective plasmid DNA delivery.
Oh SH; Kim TH; Jang SH; Im GI; Lee JH
J Biomed Mater Res A; 2011 Jun; 97(4):441-50. PubMed ID: 21484988
[TBL] [Abstract][Full Text] [Related]
4. Physicomechanical properties of sintered scaffolds formed from porous and protein-loaded poly(DL-lactic-co-glycolic acid) microspheres for potential use in bone tissue engineering.
Boukari Y; Scurr DJ; Qutachi O; Morris AP; Doughty SW; Rahman CV; Billa N
J Biomater Sci Polym Ed; 2015; 26(12):796-811. PubMed ID: 26065672
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and evaluation of a sustained-release chitosan-based scaffold embedded with PLGA microspheres.
Song K; Liu Y; Macedo HM; Jiang L; Li C; Mei G; Liu T
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1506-13. PubMed ID: 23827602
[TBL] [Abstract][Full Text] [Related]
6. Lysine-based peptide-functionalized PLGA foams for controlled DNA delivery.
Nie H; Khew ST; Lee LY; Poh KL; Tong YW; Wang CH
J Control Release; 2009 Aug; 138(1):64-70. PubMed ID: 19409431
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.
Chen SH; Wang XL; Xie XH; Zheng LZ; Yao D; Wang DP; Leng Y; Zhang G; Qin L
Acta Biomater; 2012 Aug; 8(8):3128-37. PubMed ID: 22543006
[TBL] [Abstract][Full Text] [Related]
8. The effect of poly(lactic-co-glycolic acid) (PLGA) coating on the mechanical, biodegradable, bioactive properties and drug release of porous calcium silicate scaffolds.
Zhao L; Wu C; Lin K; Chang J
Biomed Mater Eng; 2012; 22(5):289-300. PubMed ID: 23023146
[TBL] [Abstract][Full Text] [Related]
9. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
Nie H; Wang CH
J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
[TBL] [Abstract][Full Text] [Related]
10. Chondrogenesis of adipose stem cells in a porous PLGA scaffold impregnated with plasmid DNA containing SOX trio (SOX-5,-6 and -9) genes.
Im GI; Kim HJ; Lee JH
Biomaterials; 2011 Jul; 32(19):4385-92. PubMed ID: 21421267
[TBL] [Abstract][Full Text] [Related]
11. Fabricating a pearl/PLGA composite scaffold by the low-temperature deposition manufacturing technique for bone tissue engineering.
Xu M; Li Y; Suo H; Yan Y; Liu L; Wang Q; Ge Y; Xu Y
Biofabrication; 2010 Jun; 2(2):025002. PubMed ID: 20811130
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of insulin-like growth factor-1 and bone marrow stromal cell function of bone-like mineral layer-coated poly(lactic-co-glycolic acid) scaffolds.
Jayasuriya AC; Shah C
J Tissue Eng Regen Med; 2008 Jan; 2(1):43-9. PubMed ID: 18361482
[TBL] [Abstract][Full Text] [Related]
13. PHBV microspheres--PLGA matrix composite scaffold for bone tissue engineering.
Huang W; Shi X; Ren L; Du C; Wang Y
Biomaterials; 2010 May; 31(15):4278-85. PubMed ID: 20199806
[TBL] [Abstract][Full Text] [Related]
14. Functionalization of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds via surface heparinization for bone tissue engineering.
Jiang T; Khan Y; Nair LS; Abdel-Fattah WI; Laurencin CT
J Biomed Mater Res A; 2010 Jun; 93(3):1193-208. PubMed ID: 19777575
[TBL] [Abstract][Full Text] [Related]
15. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin.
Xie XH; Wang XL; Zhang G; He YX; Wang XH; Liu Z; He K; Peng J; Leng Y; Qin L
Biomed Mater; 2010 Oct; 5(5):054109. PubMed ID: 20876954
[TBL] [Abstract][Full Text] [Related]
16. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
[TBL] [Abstract][Full Text] [Related]
17. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
[TBL] [Abstract][Full Text] [Related]
18. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4).
Huang YC; Simmons C; Kaigler D; Rice KG; Mooney DJ
Gene Ther; 2005 Mar; 12(5):418-26. PubMed ID: 15647766
[TBL] [Abstract][Full Text] [Related]
19. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules.
Yilgor P; Hasirci N; Hasirci V
J Biomed Mater Res A; 2010 May; 93(2):528-36. PubMed ID: 19585564
[TBL] [Abstract][Full Text] [Related]
20. PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: in vitro evaluation in human prostate cancer cells.
Moffatt S; Cristiano RJ
Int J Pharm; 2006 Jul; 317(1):10-3. PubMed ID: 16713147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
